Smell loss is associated with cognitive impairment in amyotrophic lateral sclerosis patients
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14851 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Xin Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Cognitive Dysfunction, Olfaction Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, STI2030-Major Projects, The Chinese Academy of Sciences Grants.
Abstract (Originalsprache)
Background
Smell loss significantly impacts the quality of life in patients. However, there is limited research on smell loss in individuals with amyotrophic lateral sclerosis (ALS), and the correlation between smell loss and cognitive impairment is unclear. This study aimed to investigate the correlation between smell loss and cognition impairment in ALS patients.
Methods
The study included 216 ALS patients. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) and smell identification test specifically for the Chinese population (CSIT) were administered to evaluate participants' cognitive and olfactory function, respectively.
Results
After covarying for age, sex, BMI, education level, degree of hunger, dietary bias, eagerness for food, stress, smoking status, alcohol consumption, and upper respiratory tract infection (URTI) or rhinitis, CSIT scores were significantly correlated with ECAS scores ( r = 0.162, p = 0.028), especially the ALS‐specific scores ( r = 0.158, p = 0.031). Even after excluding patients with URTI or rhinitis, the results were similar. CSIT scores were significantly correlated with ECAS scores ( r = 0.224, p = 0.011), especially the ALS‐specific scores ( r = 0.205, p = 0.019).
Conclusion
In patients with ALS, smell loss is significantly correlated with cognitive impairment, particularly frontotemporal dysfunction. Cognitive dysfunction may lead to worse olfactory performance in ALS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Peking University Third Hospital, Beijing, China.
- Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.
- Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.
- State Key Laboratory of Brain and Cognitive Science, Chinese Academy of Sciences, Beijing, China.
- Department of Psychology, University of Chinese Academy of Sciences, Beijing, China.
- Department of Neurology, Yan'an Hospital of Traditional Chinese Medicine, Yan'an, China.
ORCID-Profile: Shan Ye
Förderung
- National Natural Science Foundation of China
- STI2030-Major Projects
- The Chinese Academy of Sciences Grants
- Beijing E-Town Cooperation & Development Foundation
- PUTH Cohort Construction Project
Zitieren
APA
Huang, X., Wu, J., Zhang, N., Teng, J., Yang, Q., Zhang, Y., Yin, T., Zhou, W., Fan, D., & Ye, S. (2024). Smell loss is associated with cognitive impairment in amyotrophic lateral sclerosis patients. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14851
Vancouver
Huang X, Wu J, Zhang N, Teng J, Yang Q, Zhang Y, et al. Smell loss is associated with cognitive impairment in amyotrophic lateral sclerosis patients. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14851
BibTeX
@article{Huang2024,
author = {Huang, Xin and Wu, Jieying and Zhang, Nan and Teng, Jinghong and Yang, Qiong and Zhang, Yingshuang and Yin, Tielun and Zhou, Wen and Fan, Dongsheng and Ye, Shan},
title = {Smell loss is associated with cognitive impairment in amyotrophic lateral sclerosis patients},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14851}
}
EUVIMED